Page last updated: 2024-09-03

3-(2,2,2-trimethylhydrazine)propionate and Body Weight

3-(2,2,2-trimethylhydrazine)propionate has been researched along with Body Weight in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (37.50)18.2507
2000's3 (37.50)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cirule, H; Dambrova, M; Kalvinsh, I; Kuka, J; Liepinsh, E; Pugovics, O; Skapare, E; Svalbe, B; Vilskersts, R1
Cirule, H; Dambrova, M; Liepinsh, E; Makrecka, M; Skapare, E; Svalbe, B1
Hagino, H; Kameyama, Y; Nagira, K; Teshima, R1
Kalvinsh, I; Kloner, RA; Sesti, C; Simkhovich, BZ1
Beauseigneur, F; Bezard, J; Boichot, J; Clouet, P; Demarquoy, J; Gresti, J; Niot, I; Rochette, L; Tsoko, M1
Arutiunian, AV; Burmistrov, SO; Konstantinova, NN; Krivtsova, EI; Oparina, TI; Pavlova, NG; Ponomarenko, IuP; Prokopenko, VM1
Asaka, N; Hayashi, Y; Kanno, T; Kirimoto, T; Matsuura, N; Miyake, H; Nakano, M1
Asaka, N; Hayashi, Y; Kirimoto, T; Matsuura, N; Miyake, H; Nakano, M; Tajima, K1

Other Studies

8 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and Body Weight

ArticleYear
Effects of long-term mildronate treatment on cardiac and liver functions in rats.
    Basic & clinical pharmacology & toxicology, 2009, Volume: 105, Issue:6

    Topics: Animals; Betaine; Biomarkers; Blood Glucose; Body Weight; Cardiovascular Agents; Carnitine; Carnitine O-Palmitoyltransferase; Dose-Response Relationship, Drug; Glucose; Heart; Hemodynamics; Lipids; Liver; Liver Glycogen; Male; Methylhydrazines; Myocardium; Rats; Rats, Wistar; Time Factors; Toxicity Tests, Chronic

2009
Anti-diabetic effects of mildronate alone or in combination with metformin in obese Zucker rats.
    European journal of pharmacology, 2011, May-11, Volume: 658, Issue:2-3

    Topics: Animals; Blood Glucose; Body Weight; Cell Nucleus; Drug Combinations; Eating; Gene Expression Regulation; Hypoglycemic Agents; Insulin; Lactic Acid; Lipid Metabolism; Male; Metformin; Methylhydrazines; Myocardium; Obesity; PPAR alpha; PPAR gamma; Rats; Rats, Zucker; RNA, Messenger

2011
Effects of minodronate on cortical bone response to mechanical loading in rats.
    Bone, 2013, Volume: 53, Issue:1

    Topics: Animals; Body Weight; Bone and Bones; Dose-Response Relationship, Drug; Female; Methylhydrazines; Rats; Rats, Wistar; Stress, Physiological

2013
Mildronate, a novel fatty acid oxidation inhibitor and antianginal agent, reduces myocardial infarct size without affecting hemodynamics.
    Journal of cardiovascular pharmacology, 2006, Volume: 47, Issue:3

    Topics: Angina Pectoris; Animals; Blood Pressure; Body Weight; Cardiovascular Agents; Fatty Acids; Female; Heart Rate; Methylhydrazines; Myocardial Infarction; Oxidation-Reduction; Rats; Rats, Sprague-Dawley

2006
Enhancement of activities relative to fatty acid oxidation in the liver of rats depleted of L-carnitine by D-carnitine and a gamma-butyrobetaine hydroxylase inhibitor.
    Biochemical pharmacology, 1995, May-17, Volume: 49, Issue:10

    Topics: Animals; Body Weight; Carnitine; Fatty Acids; gamma-Butyrobetaine Dioxygenase; Liver; Male; Methylhydrazines; Mixed Function Oxygenases; Organ Size; Oxidation-Reduction; Rats; Rats, Wistar

1995
[Mechanism of the mildronate effect on the development of rabbit embryos during placental insufficiency].
    Biulleten' eksperimental'noi biologii i meditsiny, 1998, Volume: 126, Issue:8

    Topics: Animals; Antioxidants; Body Weight; Brain; Embryonic and Fetal Development; Female; Fetal Hypoxia; Methylhydrazines; Placenta; Placental Insufficiency; Pregnancy; Rabbits; Vasodilator Agents

1998
Beneficial effects of MET-88 on left ventricular dysfunction and hypertrophy with volume overload in rats.
    Fundamental & clinical pharmacology, 1999, Volume: 13, Issue:5

    Topics: Animals; Body Weight; Cardiac Volume; Cardiomegaly; Cardiovascular Agents; Heart; Hemodynamics; Male; Methylhydrazines; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Renin; Ventricular Dysfunction, Left

1999
Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction.
    European journal of pharmacology, 2000, May-03, Volume: 395, Issue:3

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Body Weight; Cardiovascular Agents; gamma-Butyrobetaine Dioxygenase; Heart Failure; Heart Ventricles; Hemodynamics; Lactic Acid; Male; Methylhydrazines; Mixed Function Oxygenases; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Survival Rate

2000